Conference · Washington, District of Columbia
Annual Cancer Immunotherapy Conference
Health · Medicine · Life Sciences
Key numbers
- Editions on record
- 1first in 2013
About Annual Cancer Immunotherapy Conference
ARROWHEAD'S 2nd Annual Cancer Immunotherapy Conference will provide a comprehensive review of cutting edge research and development in two areas:
• Cancer Stem Cells as a new category of Targets for Immune Intervention for solid and hematological malignancies
• Hematopoietic Stem Cell and T Cell Engineering for cancer immunotherapy
The conference is bringing together leading scientists and C-Level executives from across the globe to present research, case studies and viewpoints on topics related to stem cells and cancer immunotherapy.
Conference Tracks
There will be two sequential tracks focused on the following topics:
• Tumor initiating and cancer stem cells in solid tumors: novel targets and their immunotherapeutic potential
• Novel approaches to re-direct the immune system against cancer, by engineering hematological stem cells and memory T cells
Speakers to Date Include
Adrian Bot, MD, Ph.D.,
Maurizio Chiriva-Internati, DBSc, Ph.D.,
Andrew Cornforth, Ph.D.,
Soldano Ferrone, MD, Ph.D.,
Kenneth Geles, Ph.D.,
Philip D. Greenberg, MD
Richard C. Koya, MD, Ph.D.,
and many more.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2013 | 4–5 Apr 2013 | Washington Post Conference Center Washington, District of Columbia | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Annual Cancer Immunotherapy Conference?
The next dates haven't been confirmed. The last edition we have on record was 4–5 Apr 2013.
Where is it held?
The last edition we have was at Washington Post Conference Center, Washington, District of Columbia.